Dramatic response of diffuse osteosclerosis secondary to multiple myeloma using thalidomide with melphalan and prednisolone

J Clin Oncol. 2014 Aug 10;32(23):e85-7. doi: 10.1200/JCO.2012.48.0111. Epub 2014 Feb 10.

Authors

Muhajir Mohamed¹, Terry Brain², Alhossain Khalafallah³

Affiliations

¹ Launceston General Hospital; and Launceston Clinical School, University of Tasmania, Launceston, Tasmania, Australia muhajir.mohamed@dhhs.tas.gov.au.
² Launceston General Hospital, Launceston, Tasmania, Australia.
³ Launceston General Hospital; and School of Human Life Sciences, University of Tasmania, Launceston, Tasmania, Australia.

PMID: 24516032
DOI: 10.1200/JCO.2012.48.0111

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Female
Humans
Melphalan / administration & dosage
Multiple Myeloma / complications*
Multiple Myeloma / drug therapy*
Multiple Myeloma / pathology
Osteosclerosis / drug therapy*
Osteosclerosis / etiology
Osteosclerosis / pathology
Prednisolone / administration & dosage
Thalidomide / administration & dosage

Substances

Thalidomide
Prednisolone
Melphalan